Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 83,100 shares at $58.84 ($4.9M) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Seasonal sale ($4.9M) by General Counsel and Secretary — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.76 | 4,427 | $256K | 5.2% |
| 2 | $57.76 | 4,427 | $256K | 5.2% |
| 3 | $58.84 | 16,900 | $994K | 20.1% |
| 4 | $59.86 | 27,812 | $1.7M | 33.7% |
| 5 | $59.86 | 27,812 | $1.7M | 33.7% |
| 6 | $60.31 | 861 |
| $52K |
| 1.1% |
| 7 | $60.31 | 861 | $52K | 1.1% |
| Total | $59.44 avg | 83,100 | $4.9M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |